Indo National Ltd

Indo National Limited invested Rs 50,03,864 in Medcuore Medical Solutions Private Ltd, increasing its stake in the company to 61.87% from a previous 61.09%, according to a regulatory filing on September 2, 2026. The acquisition, which involved purchasing 329 shares at prices ranging from Rs 14,056 to Rs 16,536 per share, will be completed by fiscal year 2027-28 and does not constitute a related party transaction. Medcuore Medical Solutions Private Ltd is engaged in the business of manufacturing, distribution and providing services in relation to Air Monitoring System and Air Puri?ers, with a turnover of Rs 1,45,60,000 in fiscal year 2025-26.

Indo National Limited informed the National Stock Exchange of India Limited and BSE Limited that Binu Sekhar has resigned from the position of Chief Sales Officer (CSO) of the company, effective September 1, 2026, due to personal reasons.

Indo National Ltd share price slipped 2.82% to Rs 323.7 after the company's net profit witnessed a sharp fall of 109.57% to Rs 2.01 crore, while revenue from operations improved marginally 8.42% to Rs 116.14 crore in Q2FY26 over Q1FY26. The market capitalization of Household Products industry group stocks on BSE stood at Rs 11609.51 crore, easing 5.89%. It has inched up 3.51% over last one week and gained upto 1.48% in last one month while the market capitalization of Indo National Ltd has slipped by 0.14% and 16.59% in the same period respectively. Profit before tax (PBT) of Indo National Ltd stood at Rs 3.22 crore in Q2 FY26, plunging by 370.59% year-on-year, and tanking 84.29% quarter-on-quarter. EBITDA came in at Rs 1 crore, tumbling by 232.20% YoY and crashing by 96.03% sequentially. Total expenses slightly declined by 7.13% to Rs 119.38 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 53.65 crore, soaring by 22.38% YoY, while employee benefits expense was at Rs 17.77 crore, ticking higher by 6.79% YoY. For the TTM ended FY26, revenue from operations slumped by 27.03% to Rs 467.47 crore, while net profit saw a strong growth of 732.99% to Rs 121.95 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 2520% to Rs 212.23 crore, and PBT jumped 679.04% to Rs 151.29 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 55.76 crore in FY26, as against Rs 43.55 crore in FY25. Indo National Ltd tumbled by 33.02% in last one year, underperforming the benchmark BSE Sensex which has slipped by 3.05% during the same period.

Indo National Limited will hold a board meeting on Friday, August 14, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter ending June 30, 2026, according to a regulatory filing. The company had previously closed the trading window for promoters, directors, and other connected persons from July 1, 2026, until 48 hours after the results are announced.

Indo National Limited subscribed to 9,920 fully paid-up Series A CCPS and 12,202 partly paid-up Series A1 CCPS of Aidin Technologies Private Limited for an aggregate consideration of Rs 34,99,92,034, representing 31.82% of the target entity’s paid-up share capital. The acquisition, completed on July 29, 2026, will allow Indo National to participate in the defense electronics sector, which has a market size of approximately Rs 25,000 crore and is growing at a compound annual growth rate of 12-14%, while a second tranche is expected to be completed on or before July 28, 2027.

Net loss of Indo National reported to Rs 20.91 crore in the quarter ended March 2026 as against net profit of Rs 0.08 crore during the previous quarter ended March 2025. Sales rose 10.31% to Rs 107.12 crore in the quarter ended March 2026 as against Rs 97.11 crore during the previous quarter ended March 2025. For the full year,net loss reported to Rs 26.34 crore in the year ended March 2026 as against net profit of Rs 123.76 crore during the previous year ended March 2025. Sales declined 3.21% to Rs 452.47 crore in the year ended March 2026 as against Rs 467.47 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales107.1297.11 10 452.47467.47 -3 OPM %-16.92-2.00 --4.02-4.76 - PBDT-17.180.30 PL -13.13164.53 PL PBT-20.49-2.64 -676 -26.26151.29 PL NP-20.910.08 PL -26.34123.76 PL Powered by Capital Market - Live

Indo National announced that the Board of Directors of the Company at its meeting held on 15 May 2026, inter alia, have recommended the final dividend of Rs 3.75 per equity Share (i.e. 75%) , subject to the approval of the shareholders.

Net Loss of Indo National reported to Rs 7.84 crore in the quarter ended December 2025 as against net loss of Rs 12.07 crore during the previous quarter ended December 2024. Sales declined 12.60% to Rs 106.31 crore in the quarter ended December 2025 as against Rs 121.63 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales106.31121.63 -13 OPM %-6.42-9.18 - PBDT-5.14-9.49 46 PBT-8.46-12.39 32 NP-7.84-12.07 35 Powered by Capital Market - Live

Net loss of Indo National reported to Rs 6.62 crore in the quarter ended December 2025 as against net profit of Rs 0.63 crore during the previous quarter ended December 2024. Sales declined 12.76% to Rs 106.11 crore in the quarter ended December 2025 as against Rs 121.63 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales106.11121.63 -13 OPM %-4.921.23 - PBDT-3.933.17 PL PBT-7.230.27 PL NP-6.620.63 PL Powered by Capital Market - Live

Indo National will hold a meeting of the Board of Directors of the Company on 4 February 2026.Powered by Capital Market - Live